Olesoxime Completed Phase 3 Trials for Amyotrophic Lateral Sclerosis (ALS) Other

IndicationsStatusPurposePhase
CompletedOther3
clinicaltrials.gov IdentifierTitleDrugs
NCT00868166Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From ALS